TriMas (NASDAQ:TRS - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 1.700-1.850 for the period, compared to the consensus estimate of 2.010. The company issued revenue guidance of $962.0 million-$980.5 million, compared to the consensus revenue estimate of $975.9 million.
Analysts Set New Price Targets
Several research firms have recently commented on TRS. BWS Financial reiterated a "buy" rating and set a $40.00 target price on shares of TriMas in a research note on Friday. StockNews.com raised shares of TriMas from a "sell" rating to a "hold" rating in a research report on Wednesday, November 13th.
View Our Latest Report on TRS
TriMas Stock Performance
TRS traded up $0.47 during trading hours on Monday, hitting $20.96. 531,961 shares of the stock were exchanged, compared to its average volume of 265,631. The stock has a market cap of $850.39 million, a price-to-earnings ratio of 32.75 and a beta of 0.66. The stock has a 50-day simple moving average of $23.78 and a 200-day simple moving average of $25.12. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. TriMas has a 12 month low of $19.33 and a 12 month high of $28.51.
TriMas Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 28th will be issued a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 0.76%. The ex-dividend date is Friday, February 28th. TriMas's dividend payout ratio (DPR) is presently 25.00%.
TriMas Company Profile
(
Get Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
See Also

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.